Evidence map›Paper›PMID 41373750›Full record

ArticleInternational journal of molecular sciences2025

Mapping of Determinants of Urinary Sex Steroid Metabolites During Late Pregnancy: Results from Two Spanish Cohorts.

Emily P Laveriano-Santos, Estelle Renard-Dausset, Mariona Bustamante, Dolors Pelegri, Zoraida García-Ruiz, Marina Ruiz-Rivera, Marta Cosin-Tomas, Elisa Llurba-Olive, Maria Dolores Gomez-Roig, Noemi Haro and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emily P Laveriano-SantosISGlobal, 08003 Barcelona, Spain.ORCID 0000-0002-4852-6074
Estelle Renard-DaussetISGlobal, 08003 Barcelona, Spain.
Mariona BustamanteISGlobal, 08003 Barcelona, Spain.
Dolors PelegriISGlobal, 08003 Barcelona, Spain.ORCID 0000-0002-5993-3003
Zoraida García-RuizISGlobal, 08003 Barcelona, Spain.ORCID 0009-0009-4631-763X
Marina Ruiz-RiveraISGlobal, 08003 Barcelona, Spain.
Marta Cosin-TomasISGlobal, 08003 Barcelona, Spain.
Elisa Llurba-OliveInstitut de Investigació Biomèdica Sant Pau-IIB San Pau, 08041 Barcelona, Spain.
Maria Dolores Gomez-RoigBCNatal-Barcelona Center for Maternal, Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, University of Barcelona, 08028 Barcelona, Spain.
Noemi HaroHospital del Mar Research Institute, 08003 Barcelona, Spain.
Óscar J PozoHospital del Mar Research Institute, 08003 Barcelona, Spain.
Payam DadvandISGlobal, 08003 Barcelona, Spain.ORCID 0000-0002-2325-1027
Martine VrijheidISGlobal, 08003 Barcelona, Spain.ORCID 0000-0002-7090-1758
Léa MaitreISGlobal, 08003 Barcelona, Spain.ORCID 0000-0003-3682-7117

Funding

AGAUR-Agència de Gestió d'Ajuts Universitaris de Recerca 2021 SGR 01570 - Population Neuroscience groupAgence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES) (2019/01/039 - HyPAXE projectBiSC genome-wide genotyping data was funded by the Instituto de Salud Carlos III and co-funded by European Union (ERDF) "A way to make Europe" PI20/01116 - ENTENTE projectCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) CB06/02/0041European Union's Horizon 2020 research and innovation programme 785994 - AirNB projectEuropean Union's Horizon 2020 research and innovation programme-EU.3.1.2. 874583 - ATHLETE projectGeneralitat de Catalunya-CIRIT 1999SGR 00241H2020-EU.3.1.1. GA964827 - AURORA projectHealth Effects Institute (4959-RFA17-1/18-1 - FRONTIER projectInstituto de Salud Carlos III INMA G03/176Instituto de Salud Carlos III (ISCIII) and the European Union Next Generation EU - Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin Network (RICORS-SAMID) RD21/0012/0001 and RD21/0012/0003ISCIII-AES-2021/001814 FIS 2021 - IGRO PI21/01269Maternal and Child Health and Development Network (SAMID) (RD16/0022/0014 and RD16/0022/0015MCIN/AEI/ 10.13039/501100011033 CEX2023-0001290-SMICIU/AEI/10.13039/501100011033 JDC2022-049842-IMICIU/AEI/10.13039/501100011033 RYC2022-036475-I
6 · The paper itself

Abstract

Steroid hormones (SHs), including sex steroids and corticosteroids, are crucial for a healthy pregnancy. We aimed to comprehensively characterize the maternal SH metabolome in late pregnancy and identify clinical, lifestyle, and sociodemographic determinants influencing SH metabolism with a replication in an independent cohort. Urinary SH metabolites were analyzed in 1221 third-trimester pregnant women (aged 28 to 37 years) from two Spanish cohorts, BiSC (2018-2021,

Indexed as

Gonadal Steroid HormonesPregnancy Trimester, ThirdAdultCohort StudiesFemaleHumansMetabolomePregnancySpainTandem Mass SpectrometryGonadal Steroid Hormonesconjugated metabolitesmaternal metabolomemetabolic yprofilingphase II metabolismsteroidomicsurinary steroid prolife

Identifiers

PMID41373750
PMCPMC12692236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.